C4 THERAPEUTICS INC. - COMMON STOCK
4.2500
22-11月-24 16:44:58
15 分の遅延
株式
+0.2400
+5.99%
本日の幅
3.9100 - 4.3385
ISIN
N/A
ソース
NASDAQ
-
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
04 5 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
19 4 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
23 2 2023 07:00:02 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Two Virtual February 2023 Conferences
08 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
30 1 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
09 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
03 11 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022
26 9 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
04 8 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
02 8 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
05 5 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
08 4 2022 13:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
16 3 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
09 3 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
08 3 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
24 2 2022 07:00:03 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
10 1 2022 07:00:02 提供 Nasdaq GlobeNewswire